Research + Discoveries

Derbyshire Lab and Pharmacology Collaborators Spur Cell Death in Tumors

A recent molecule, Takinib, developed by the Derbyshire and Haystead's labs, has been found to induce cell death in cancer cells by inhibiting the enzyme TAK-1.  Current testing is focused on Takinib’s possible therapeutic benefits in rheumatoid arthritis and could potentially expand to focus on other diseases, such as malaria.  Read more about this exciting molecule in the recent edition of Cell Chemical Biology.